Drugs / Phosphatidylcholine Deoxycholate
last change Oct 2009 re-read 3 minutes ago

Phosphatidylcholine Deoxycholate

Developed for
obesity disorder
Investigated by
The Cleveland Clinic

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT00851747 Feb → Oct 2009 obesity disorder The Cleveland Clinic Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Phosphatidylcholine Deoxycholate ClinicalTrials.gov intervention name — accepted as the source's own label NCT00851747 ↗
Route Subcutaneous “Subcutaneous injections of the study drug” NCT00851747 ↗